Starting August 1, 2024, Quickarrays, Inc. will be providing all products and services in place of Pantomics Inc.
SERVICES
CUSTOM TMA
ROUTINE PATHOLOGY
IHC / IMMUNOFLUORESCENCE
ISH / FISH
CONTRACTED SERVICES
PRIMARY IHC ANTIBODIES
PATHOLOGY FIELD
Hermatopathology
DETECTION SYSTEMS
ANCILLARIES
CONTROL TMA
NPC111
Nasopharyngeal carcinoma tissue array, NPC111, non-overlapping with NPC481, NPC961, NPC962, NPC1501, NPC1502 or NPC1503, containing 8 cases of primary tumors and 3 cases of normal/reactive nasopharyngeal mucosal tissues.
Specification
Data Sheet
TNM Grading
Downloads
Price
Size
Availability
Inquire
1 slide
In-Stock
A | |
B | |
TNM Classification : Nasopharygeal carcinoma
T - Primary Tumor
TX - Primary tumor cannot be assessed
T0 - No evidence of primary tumor
Tis - Carcinoma in situ
T1 - Tumor confined to nasopharynx
T2 - Tumor estends to soft tissue of oropharynx and/or nasal fossa
T2a – without parapharyngeal extension
T2b – with parapharyngeal extension
T3 - Tumor invades bony structures and/or paranasal sinuses
T4 - Tumor with intracranial extension and/or involvement of cranial nerves, infratemporal fossa, hypopharynx, or orbit
N - Regional Lymph nodes
NX - Reginal lymph nodes cannot be assessed
N0 - No regional lymph node metastasis
N1 - Unilateral metastasis in lymph node(s), 6cm or less in greatest dimension, above supraclavicular fossa
N2 - Bilateral metastasis in lymph node(s), 6cm or less in greatest dimension, above supraclavicular fossa
N3 - Metastasis in lymph node(s)
(a) greater than 6cm in dimension
(b) in the supraclavicular
M - Distant Metastasis
MX - Distant metastasis cannot be assessed
M0 - No distant metasissis
M1 - Distant metastasis
Human
11
11
1.5mm
4um
2
8
Paraffin
Notes:
All tissues were fixed in 10% neutral buffered formalin for 24 hours and processed using identical SOPs. Sections were picked onto Superfrost Plus or Startfrost Adhesive slides. They all have a guaranteed six month shelf-life at 4C from the date of shipment. Additional cores not listed are orientation markers and have no data. There maybe <5% core loss per slide but the core retention rate should be >90%.
Bake at 60C for 30 minutes before use. If antigen retrieving is needed, it is always a good idea to start with a protocol with weak to mild strength. Please check our TNM guide as a reference. For IHC related information on products that provide them, please contact us at info@pantomics.com for the most up-to-date information.
For research use only. Designed for IHC or ISH based protein or RNA tissue profiling in nasopharyngeal carcinoma.
ARRAY POSITION | IMAGE | SEX | AGE | ANATOMIC SITE | PATHOLOGY | GRADE | STAGE (TNM) |
---|---|---|---|---|---|---|---|
A01 | F | 48 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T3N0M0 | |
A02 | F | 74 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T1N2M0 | |
A03 | M | 58 | Head and neck, nasopharynx | Undifferentiated carcinoma | T4N0M0 | ||
A04 | F | 33 | Head and neck, nasopharynx | Squamous cell carcinoma | III | ||
A05 | M | 40 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T3N3M0 | |
A06 | F | 33 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T2N0M0 | |
A07 | M | 41 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T2N0M0 | |
A08 | M | 54 | Head and neck, nasopharynx | Squamous cell carcinoma | III | T3N0M0 | |
B01 | M | 70 | Head and neck, nasopharynx | Normal mucosa | |||
B02 | M | 20 | Head and neck, nasopharynx | Normal mucosa | |||
B03 | M | 16 | Head and neck, nasopharynx | Normal mucosa | |||
null |